Concert Pharma Initiates Phase 1 Single-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia Read more
Basilea Announces Collaboration to Study Derazantinib and Atezolizumab (Tecentriq) in Urothelial Cancer Read more
Rigel Enters Collaboration and License Agreement with Grifols to Commercialize Fostamatinib in Europe Read more